Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 20.86
+0.16 (0.77%)
May 15, 2026, 2:17 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 810.93 million as of May 15, 2026. Its market cap has decreased by -2.39% in one year.
Market Cap
810.93M
Enterprise Value
796.36M
Revenue
115.82M
Ranking
n/a
PE Ratio
400.89
Stock Price
20.86
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 810.93M, a decrease of -75.05%. That is a compound annual growth rate of -12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 810.93M | -24.63% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 256.53B |
| Novartis AG | 222.87B |
| Galderma Group AG | 38.33B |
| Lonza Group AG | 33.39B |
| PolyPeptide Group AG | 1.24B |
| Cosmo | 1.22B |
| Idorsia | 1.17B |
| Aevis Victoria | 1.11B |